Inhibition of lipoprotein-associated phospholipase activity by darapladib - Shifting gears in cardiovascular drug development: Are antiinflammatory drugs the next frontier?

被引:12
作者
Boekholdt, S. Matthijs [1 ,2 ]
de Winter, Robbert J. [2 ]
Kastelein, John J. P. [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands
关键词
editorials; atherosclerosis; drugs; inflammation; lipids;
D O I
10.1161/CIRCULATIONAHA.108.795195
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1120 / 1122
页数:3
相关论文
共 23 条
[1]   Inhibition of lipoprotein-associated phospholipase A2 diminishes the death-inducing effects of oxidised LDL on human monocyte-macrophages [J].
Carpenter, KLH ;
Dennis, IF ;
Challis, IR ;
Osborn, DP ;
Macphee, CH ;
Leake, DS ;
Arends, MJ ;
Mitchinson, MJ .
FEBS LETTERS, 2001, 505 (03) :357-363
[2]   Platelet-activating factor acetylhydrolase: is it good or bad for you? [J].
Chen, CH .
CURRENT OPINION IN LIPIDOLOGY, 2004, 15 (03) :337-341
[3]   Characterization of plaque components with intravascular ultrasound elastography in human femoral and coronary arteries in vitro [J].
de Korte, CL ;
Pasterkamp, G ;
van der Steen, AFW ;
Woutman, HA ;
Bom, N .
CIRCULATION, 2000, 102 (06) :617-623
[4]  
Diethrich EB, 2007, J ENDOVASC THER, V14, P676, DOI 10.1583/1545-1550(2007)14[676:VHIUAO]2.0.CO
[5]  
2
[6]   Effect of a multifactorial intervention on mortality in type 2 diabetes [J].
Gaede, Peter ;
Lund-Andersen, Henrik ;
Parving, Hans-Henrik ;
Pedersen, Oluf .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (06) :580-591
[7]   Comparison of virtual histology to intravascular ultrasound of culprit coronary lesions in acute coronary syndrome and target coronary lesions in stable angina pectoris [J].
Hong, Myeong-Ki ;
Mintz, Gary S. ;
Lee, Cheol Whan ;
Suh, Jon ;
Kim, Jeong-Hoon ;
Park, Duk-Woo ;
Lee, Seung-Whan ;
Kim, Young-Hak ;
Cheong, Sang-Sig ;
Kim, Jae-Joong ;
Park, Seong-Wook ;
Park, Seung-Jung .
AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (06) :953-959
[8]   Lipoprotein-associated phospholipase A2 predicts future cardiovascular events in patients with coronary heart disease independently of traditional risk factors, markers of inflammation, renal function, and hemodynamic stress [J].
Koenig, Wolfgang ;
Twardella, Dorothee ;
Brenner, Hermann ;
Rothenbacher, Dietrich .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (07) :1586-1593
[9]   Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis [J].
Kolodgie, Frank D. ;
Burke, Allen P. ;
Skorija, Kristi S. ;
Ladich, Elena ;
Kutys, Robert ;
Makuria, Addisalem Taye ;
Virmani, Renu .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (11) :2523-2529
[10]   Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997 [J].
Laatikainen, T ;
Critchley, J ;
Vartiainen, E ;
Salomaa, V ;
Ketonen, M ;
Capewell, S .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2005, 162 (08) :764-773